We, therefore, observe industry trends closely, including navigating how the industry builds closer relationships with patients, evolving commercial strategies… $160,000 – $180,000 a yearFrom Alvarez and marsal – Wed, 01 Feb 2023 02:19:22 GMT – […]
SAN FRANCISCO–(BUSINESS WIRE)–Radiance Therapeutics, Inc. (RadianceTx®), an innovation leader in ophthalmic devices, today announced that Dr. Laurence Marsteller, Chief Executive Officer, will present the company at the Glaucoma Research Foundation headline event, Glaucoma 360 New […]
PALO ALTO, Calif.–(BUSINESS WIRE)–Imagine dishes from the most iconic restaurants and chefs from around the world delivered to your doorstep. No passport required. Just order and enjoy! Food technology startup CloudChef has made this a […]
Gilead is calling it quits on a two-year-old project to develop an oral formulation of its Covid-19 antiviral remdesivir, its biotech counterparts at Matinas BioPharma reported. Instead, Gilead told Matinas that it’s focusing on an […]
SAN FRANCISCO–(BUSINESS WIRE)–Quantum Industry Canada (QIC), Quantum Economic Development Consortium (QED-C), Quantum Strategic Industry Alliance for Revolution (Q-STAR) and European Quantum Industry Consortium (QuIC) signed a memorandum of understanding (MoU) to formally establish the International […]
Amgen’s long-awaited pricing for its Humira biosimilar suggests the biggest winners may be health insurers and others in the supply chain, but not patients. Click to view original post
“Once again, warped incentives baked into the U.S. drug channel will limit savings from biosimilars,” said Adam Fein of Drug Channels Institute. Click to view original post
AMGEN ALSO PROVIDES 2023 GUIDANCE EXCLUDING ANY CONTRIBUTION FROM THE ANNOUNCED ACQUISITION OF HORIZON THERAPEUTICS THOUSAND OAKS, Calif., Jan. 31, 2023 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and […]
WALTHAM, Mass.–(BUSINESS WIRE)– #DrugDiscovery–X-Chem, the leading provider of innovative solutions in early-stage drug discovery, expands collaboration with Kymera Therapeutics, Inc. Click here to view original post
SAN DIEGO–(BUSINESS WIRE)–Arima Genomics announces an agreement with Protean BioDiagnostics to make their gene fusion test widely available to clinicians. Click here to view original post
© 2022 Biotech Networks, LLC
